Form 4: Medtronic EVP Ivan K. Fong Reports Stock Transactions
SEC Form 4 Filing
EVP and General Counsel of Medtronic, Ivan K. Fong, reports the acquisition and disposal of Medtronic plc ordinary shares related to performance share unit settlements and tax withholdings.
Summary
- On August 2, 2024, Ivan K. Fong, EVP, General Counsel & Secretary of Medtronic plc, reported transactions involving Medtronic ordinary shares.
- These transactions include the acquisition of 8,370 shares and 6,144 shares upon the settlement of performance-vesting restricted stock units.
- Additionally, 3,423 shares and 2,802 shares were disposed of to cover tax obligations related to the settlement of these units at a price of $81.51.
- Another 2,985 shares were withheld for taxes upon the vesting of restricted stock units.
- Following these transactions, Fong directly owns 57,963 Medtronic ordinary shares.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to the market regarding the actions of company executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Date of grant for performance-vesting restricted stock units. |
| 08/02/2024 | Date of transactions: settlement of performance-vesting restricted stock units, tax withholdings. |
| 08/06/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.